Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05778344
Other study ID # 202106133RIND
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 12, 2023
Est. completion date December 2023

Study information

Verified date April 2023
Source National Taiwan University Hospital
Contact Ping-Lun Hsieh, MSc
Phone +886-905925933
Email 107673@ntuh.gov.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the efficacy of a home-based pulmonary rehabilitation program with the support of teletechnology in COVID-19 survivors. The main questions it aims to answer are: - The change of six-minute walk distance - The change of time of one-minute sit-to-stand test - The change of maximal strength of upper-limb, lower-limb and respiratory muscle - The change of quality of life Participants in the home-based pulmonary rehabilitation group will receive teletechnology-assisted consultations (either by videotelephony or telephone calls) for every 1-2 weeks during the intervention period, and participants in the usual care group will not receive teletechnology-assisted consultations during the intervention period.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Patients are 20 years or more with severe (severe pneumonia) to critical (acute respiratory distress syndrome, sepsis, or septic shock) COVID-19 during hospitalization after deisolation. - Patients are 65 years or more, or ever receiving oral antiviral treatment after deisolation. - Patient have the ability to ambulate on level surface without direct contact of another person, have telecommunication device(s), and provide consent to receive teletechnology-assisted rehabilitation. Exclusion Criteria: - Patients are pregnant or planning for pregnancy. - Patients have cognitive dysfunction, learning disability, uncontrolled arrhythmia or hypertension, or any medical diagnosis other than COVID-19 that would prominently influence their ability to follow instructions and perform exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Teletechnology-assisted home-based pulmonary rehabilitation
The accuracy and safety of home-based pulmonary rehabilitation will be checked regularly through technology devices such as smart watch and via videotelephony (or telephone calls if indicated).

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei City

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (3)

Betschart M, Rezek S, Unger I, Beyer S, Gisi D, Shannon H, Sieber C. Feasibility of an Outpatient Training Program after COVID-19. Int J Environ Res Public Health. 2021 Apr 9;18(8):3978. doi: 10.3390/ijerph18083978. — View Citation

Felten-Barentsz KM, van Oorsouw R, Klooster E, Koenders N, Driehuis F, Hulzebos EHJ, van der Schaaf M, Hoogeboom TJ, van der Wees PJ. Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19. Phys Ther. 2020 Aug 31;100(9):1444-1457. doi: 10.1093/ptj/pzaa114. — View Citation

Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N, Vogelmeier CF, Kenn K, Koczulla AR. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021 May 31;7(2):00108-2021. doi: 10.1183/23120541.00108-2021. eCollection 2021 Apr. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Six-minute walk distance The distance of six-minute walk test Week 0
Primary Six-minute walk distance The distance of six-minute walk test Week 4
Primary Six-minute walk distance The distance of six-minute walk test Week 8
Primary Six-minute walk distance The distance of six-minute walk test Week 12
Primary Six-minute walk distance The distance of six-minute walk test Week 24
Secondary Maximal upper limb strength Hand grip strength Week 0
Secondary Maximal upper limb strength Hand grip strength Week 4
Secondary Maximal upper limb strength Hand grip strength Week 8
Secondary Maximal upper limb strength Hand grip strength Week 12
Secondary Maximal upper limb strength Hand grip strength Week 24
Secondary Maximal lower limb strength Leg press strength Week 0
Secondary Maximal lower limb strength Leg press strength Week 4
Secondary Maximal lower limb strength Leg press strength Week 8
Secondary Maximal lower limb strength Leg press strength Week 12
Secondary Maximal lower limb strength Leg press strength Week 24
Secondary Maximal respiratory muscle strength Inspiratory and expiratory pressure of respiratory muscle Week 0
Secondary Maximal respiratory muscle strength Inspiratory and expiratory pressure of respiratory muscle Week 4
Secondary Maximal respiratory muscle strength Inspiratory and expiratory pressure of respiratory muscle Week 8
Secondary Maximal respiratory muscle strength Inspiratory and expiratory pressure of respiratory muscle Week 12
Secondary Maximal respiratory muscle strength Inspiratory and expiratory pressure of respiratory muscle Week 24
Secondary Quality of life score Quality of life assessed by Short-form 12 questionnaire Week 0
Secondary Quality of life score Quality of life assessed by Short-form 12 questionnaire Week 4
Secondary Quality of life score Quality of life assessed by Short-form 12 questionnaire Week 8
Secondary Quality of life score Quality of life assessed by Short-form 12 questionnaire Week 12
Secondary Quality of life score Quality of life assessed by Short-form 12 questionnaire Week 24
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure